40,000 Instrumented Timed-up-and-go Tests – Standardization is within Reach
Objective: Timed-up-and-go (TUG) is a standard test in neurological assessment. TUG completion time is currently the only quantitative result reported and matched against age and…Drug-induced parkinsonism with resting tremor
Objective: Resting tremor might be developed by long-term treatment of dopamine receptor antagonists in cases of drug-induced parkinsonism Background: Resting tremor is one of the…Parkinsonism following Chronic Disulfiram Overdose
Objective: To describe the effect of chronic intake of disulfiram Background: Background- Drug induced parkinsonism is one of the commonest causes of non-degenerative parkinsonism. Typical…Drug-induced Parkinsonism Mimicking Parkinson´s Disease in Patients Treated with Flunarizine for Migraine
Objective: To understand the pattern of movement disorders caused by migraine prophylactic medicine such as flunarizine. Background: Migraine prophylactic treatments are usually taken for short…Neuroprotective Role of Diosgenin-Loaded Lipid Nanoparticles for Parkinson’s Disease: Pharmacokinetic and Pharmacodynamic Insights
Objective: To develop, optimize, and evaluate diosgenin-loaded solid lipid nanoparticles (DG-SLNs) and nanostructured lipid carriers (DG-NLCs) incorporated into hydrogel formulations (DG-SLN-C and DG-NLC-C) for improved…Cerebellar Syndrome and Parkinsonism Associated with Acquired Hepatocerebral Degeneration with Unusual Findings on Neuroimaging.
Objective: To present a clinical case of cerebellar syndrome and parkinsonism linked to acquired hepatocerebral degeneration exhibiting atypical radiological abnormalities. Background: Acquired hepatocerebral degeneration (AHCD)…Carvacrol modulates rotenone-induced Nigrostriatal Neuronal Death and Angiogenesis via targeting AMPK/FOXO3 transcription factor O3 Signaling cascade
Objective: With an eye toward its effects on striatal angiogenesis and the AMPK/ FOXO3 transcription factor O3 pathway, this work attempts to investigate the neuroprotective…Quantitative EEG Analysis for Comparing Drug-Induced Parkinsonism and Parkinson’s Disease
Objective: To know whether EEG could be a neural indicator that distinguish between Drug-induced parkinsonism (DIP) and Parkinson’s disease (PD). Background: DIP is the second…Prevalence of Movement Disorders in Epilepsy Patients Taking Antiepileptics Drugs in a Tertiary Care Teaching Hospital in Nepal.
Objective: To assess the prevalence of movement disorders in epilepsy patients taking antiepileptics drugs. Background: A prospective longitudinal observational study was conducted for one year…No Association between Anemia and Risk of Parkinson’s Disease: Evidence From A Meta-Analysis Using Real-World Evidence
Objective: To explore the association between anemia and the risk of Parkinson’s disease. Background: Parkinson’s disease (PD) is a common progressive neurodegenerative neurological disorder. More than…
- 1
- 2
- 3
- …
- 10
- Next Page »